Compound | Concentration (µg/ml) | % Cell Viability (Mean ± SEM) | IC50 value (µg/ml) |
---|---|---|---|
NC | – | 100% | – |
Sta. (5-FU) | 640 | 10.58 ± 1.17*** | 1.66 |
160 | 20.25 ± 1.23*** | ||
40 | 28.87 ± 1.28*** | ||
PEE | 640 | 42.32 ± 1.63 | 502.70 |
320 | 57.04 ± 1.61 | ||
160 | 68.63 ± 2.37 | ||
80 | 73.97 ± 2.04 | ||
40 | 80.16 ± 1.87 | ||
20 | 87.29 ± 2.31 | ||
CHCl3E | 640 | 42.11 ± 1.69 | 497.70 |
320 | 56.66 ± 2.47 | ||
160 | 69.27 ± 2.27 | ||
80 | 73.88 ± 1.37 | ||
40 | 79.70 ± 1.68 | ||
20 | 87.21 ± 1.47 | ||
EAE | 640 | 40.49 ± 2.42* | 165.67 |
320 | 46.70 ± 1.58* | ||
160 | 50.97 ± 2.88 | ||
80 | 52.81 ± 1.78 | ||
40 | 56.92 ± 1.47 | ||
20 | 68.75 ± 1.86 | ||
ETHE | 640 | 37.84 ± 2.52** | 35.873 |
320 | 39.71 ± 1.98** | ||
160 | 43.88 ± 2.02 | ||
80 | 46.74 ± 1.43 | ||
40 | 49.86 ± 1.67 | ||
20 | 52.09 ± 2.30 | ||
AQE | 640 | 40.10 ± 1.82 | 419.89 |
320 | 54.60 ± 2.81 | ||
160 | 67.29 ± 1.95 | ||
80 | 71.53 ± 2.22 | ||
40 | 77.96 ± 1.55 | ||
20 | 85.05 ± 2.08 |